SAR-442999

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSAR-442999
Drug Alias NameAnti-TNF-alpha/IL-23 nanobody (Sanofi)Dual TNF-Alpha/IL-23 Inhibitor (Sanofi)SAR-442999
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionInterleukin-23 inhibitorsTumor necrosis factor inhibitors
TargetsInterleukin-23Tumor necrosis factor
Therapy Area/IndicationsInflammationImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi-Aventis Groupe
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi-Aventis Groupe
Active IndicationsN/A
Inactive IndicationsInflammationImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A